Market report: Anagen makes comeback
ANAGEN, a failed drugs business, is making a market comeback. It is taking over Gander, a property group, in a share exchange deal which will allow Gander to use Anagen's pounds 27m of losses to offset future profits. Anagen was delisted last year and is now a shell.
William Cairns, who put up the sum of pounds 200,000 to save the company from liquidation, will have 3 per cent of the combined group. Gander's share price rose 0.25p to 7p.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies